145 related articles for article (PubMed ID: 21190299)
21. Toll-like receptor signaling in anti-cancer immunity.
Okamoto M; Sato M
J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
[TBL] [Abstract][Full Text] [Related]
22. Regulatory B cells in ANCA-associated vasculitis.
Wilde B; Thewissen M; Damoiseaux J; Knippenberg S; Hilhorst M; van Paassen P; Witzke O; Cohen Tervaert JW
Ann Rheum Dis; 2013 Aug; 72(8):1416-9. PubMed ID: 23666929
[TBL] [Abstract][Full Text] [Related]
23. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.
Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY
Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348
[TBL] [Abstract][Full Text] [Related]
24. TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Biochem Biophys Res Commun; 2006 Jan; 339(4):1048-55. PubMed ID: 16337148
[TBL] [Abstract][Full Text] [Related]
25. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
26. The expression of Toll-like receptors 2, 4 and 9 in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
Wang H; Gou SJ; Zhao MH; Chen M
Clin Exp Immunol; 2014 Sep; 177(3):603-10. PubMed ID: 24773611
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
28. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif.
Lichtnekert J; Vielhauer V; Zecher D; Kulkarni OP; Clauss S; Segerer S; Hornung V; Mayadas TN; Beutler B; Akira S; Anders HJ
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F867-74. PubMed ID: 19158348
[TBL] [Abstract][Full Text] [Related]
29. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
30. Effect of high mobility group box 1 on Toll-like receptor 9 in B cells in myeloperoxidase-ANCA-associated vasculitis.
Wang C; Deng H; Gong Y; You R; Chen M; Zhao MH
Autoimmunity; 2020 Feb; 53(1):28-34. PubMed ID: 31790283
[TBL] [Abstract][Full Text] [Related]
31. Differential involvement of Th1 and Th17 in pathogenic autoimmune processes triggered by different TLR ligands.
Shi G; Vistica BP; Nugent LF; Tan C; Wawrousek EF; Klinman DM; Gery I
J Immunol; 2013 Jul; 191(1):415-23. PubMed ID: 23720812
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of small vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models.
Kain R; Firmin DA; Rees AJ
Curr Opin Rheumatol; 2010 Jan; 22(1):15-20. PubMed ID: 19823088
[TBL] [Abstract][Full Text] [Related]
33. Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability.
Dzopalic T; Dragicevic A; Vasilijic S; Vucevic D; Majstorovic I; Bozic B; Balint B; Colic M
Int Immunopharmacol; 2010 Nov; 10(11):1428-33. PubMed ID: 20817120
[TBL] [Abstract][Full Text] [Related]
34. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
[TBL] [Abstract][Full Text] [Related]
35. BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligands.
Alsaleh G; Messer L; Semaan N; Boulanger N; Gottenberg JE; Sibilia J; Wachsmann D
Arthritis Rheum; 2007 Oct; 56(10):3202-14. PubMed ID: 17907168
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin receptor-dependent regulation of Th1 and Th17 responses in autoimmune diseases: comment on the article by Chen et al.
Leng RX; Pan HF; Ye DQ
Arthritis Rheum; 2011 Feb; 63(2):568; author reply 568-9. PubMed ID: 21280012
[No Abstract] [Full Text] [Related]
37. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
38. Ageing enhances cellular immunity to myeloperoxidase and experimental anti-myeloperoxidase glomerulonephritis.
Alikhan MA; Jaw J; Shochet LR; Robson KJ; Ooi JD; Brouwer E; Heeringa P; Holdsworth SR; Kitching AR
Rheumatology (Oxford); 2022 May; 61(5):2132-2143. PubMed ID: 34508583
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
[TBL] [Abstract][Full Text] [Related]
40. Animal models of systemic vasculitis.
Mathieson PW; Qasim FJ; Esnault VL; Oliveira DB
J Autoimmun; 1993 Apr; 6(2):251-64. PubMed ID: 8388693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
